Translate this page into:
Authors’ response
*For correspondence: dr_vishaltandon@yahoo.com
This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
We appriciate the intrest shown by Gozdas and Arpaci from Turkey.
In reply to their remarks we would like to state that our study had some limitations. It did not represent the true prevalence of the problem due to voluntary/spontaneous nature of reporting. Risk factor correlation was not done in this study. The data were generated by spontaneous reporting system as proposed by Pharmacovigilance Programme of India (PvPI). Thus, there might be many other confounding factors which could have affected the final outcome of the study. No attempt was made to establish any statistical correlation as it was beyond the scope of the study. This has been stated in the last paragraph of discussion also under limitations of the stduy. Thus age, gender and co-morbidities as risk factors for drug-induced diseases cannot be concluded from the results of our study. The results only depicted the distributioin as these were reported.
